An update and future directions in advanced gastric or gastrointestinal junction cancer (G/GEJC)

被引:0
|
作者
不详
机构
关键词
OPEN-LABEL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:109 / 112
页数:4
相关论文
共 50 条
  • [1] Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
    Bai, Rilan
    Chen, Naifei
    Liang, Tingting
    Li, Lingyu
    Lv, Zheng
    Lv, Xiaomin
    Cui, Jiuwei
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Prognostication in advanced cancer: update and directions for future research
    David Hui
    Carlos Eduardo Paiva
    Egidio G. Del Fabbro
    Christopher Steer
    Jane Naberhuis
    Marianne van de Wetering
    Paz Fernández-Ortega
    Tatsuya Morita
    Sang-Yeon Suh
    Eduardo Bruera
    Masanori Mori
    [J]. Supportive Care in Cancer, 2019, 27 : 1973 - 1984
  • [3] Prognostication in advanced cancer: update and directions for future research
    Hui, David
    Paiva, Carlos Eduardo
    Del Fabbro, Egidio G.
    Steer, Christopher
    Naberhuis, Jane
    van de Wetering, Marianne
    Fernandez-Ortega, Paz
    Morita, Tatsuya
    Suh, Sang-Yeon
    Bruera, Eduardo
    Mori, Masanori
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (06) : 1973 - 1984
  • [4] HER2 AND OTHER BIOMARKER TESTING PATTERNS AMONG PATIENTS WITH ADVANCED GASTRIC CANCER (GC) OR GASTRIC ESOPHAGEAL JUNCTION CANCER (GEJC)
    Mehta, S.
    Herms, L.
    Chou, L. N.
    Lam, C. K.
    Kwong, W. J.
    Cosgrove, D.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S497 - S497
  • [5] Management update and future directions in the treatment of locally advanced breast cancer
    Pierce, LJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 106 - 106
  • [6] Immunological and biochemical modulation in the treatment of advanced colorectal cancer: Update and future directions
    Hilgenfeld, RU
    Kreuser, ED
    [J]. ATTEMPTS TO UNDERSTAND METASTASIS FORMATION III: THERAPEUTIC APPROACHES FOR METASTASIS TREATMENT, 1996, 213 : 217 - 240
  • [7] Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions
    Richards, Donald A.
    Boehm, Kristi A.
    Anthony, Stephen P.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 1059 - 1068
  • [8] The potential drug cost impact of nivolumab (N) in patients with advanced/metastatic gastric cancer (GC) or gastroesophageal junction cancer (GEJC) in Canada.
    Virik, Kiran
    Wilson, Robert B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [9] Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review
    Ratti, Margherita
    Orlandi, Elena
    Toscani, Ilaria
    Vecchia, Stefano
    Anselmi, Elisa
    Hahne, Jens Claus
    Ghidini, Michele
    Citterio, Chiara
    [J]. CANCERS, 2024, 16 (15)
  • [10] Colon Cancer: An Update and Future Directions INTRODUCTION
    Yang, Vincent W.
    Lewis, James
    Wang, Timothy C.
    Rustgi, Anil K.
    [J]. GASTROENTEROLOGY, 2010, 138 (06) : 2027 - 2028